|
Hi! We all know that patient advocacy shows up differently across organizations. Sometimes it sits within medical. Sometimes commercial. Sometimes corporate affairs. Sometimes it stands alone. Where it sits changes how we tell those stories, and how the patient voice ultimately shows up in our narratives. Our inaugural Patient Advocacy & Engagement Roundtable panel brings together leaders who have overseen advocacy from multiple vantage points, including within integrated corporate affairs functions and organization-wide patient centricity roles. Patient Stories Without a Fixed Address📅 Thursday, March 5th | 12-1 p.m. ET We’ll examine:
This conversation is designed for communicators operating at the enterprise level, those shaping brand, policy, investor, and employee narratives while ensuring patient voices are reflected with care and credibility. Meet our panelists:
Thank you to our PA&E Roundtable members for curating a thoughtful first session. Lynnea P.S. - Missed a previous roundtable discussion? The T2B Dashboard for Pro and Student members houses session replays and member resources. |
Hi! At our February Comm Convo, Fighting Misinformation Without Amplifying It, we examined the practical reality biopharma communicators navigate every day: A fast-moving information environment where incomplete, misleading, or distorted claims can gain traction quickly. There is rarely a clean or standard how-to for responding when misinformation spreads. Instead, effective responses depend on preparation, cross-functional alignment, and disciplined judgment about when engagement adds...
Hi! A quick reminder that tomorrow is our inaugural PA&E Roundtable event. Wherever the patient advocacy function formally sits in an organization research, communicators are often the ones helping translate those patient insights into stories that resonate internally and externally. Tomorrow’s conversation will explore how teams gather those insights, how communicators partner across functions, and what it takes to represent patient experiences thoughtfully and responsibly in our work. The...
Hi! As we know all too well, life sciences comms comes with a unique set of complexities, from regulatory constraints, to deep investor scrutiny, to audiences with technical expectations. But many of the challenges we face aren’t truly one-of-a-kind to our sector. Across industries, communicators wrestle with trust, ambiguity, executive counsel under pressure, and shifting stakeholder dynamics. Our March Comm Convo brings together communicators who have worked in and out of life sciences to...